CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 

Abbott Laboratories  (ABT)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 

Abbott Laboratories

ABT's Financial Statements and Analysis




       
 
Abbott Laboratories reported III. Quarter net loss per share of $-0.22 compare to earnings per share of $0.38 in the same quarter a year ago a decrease from $0.41 eps realized in II. Quarter (Jun 30 2016).

More on ABT's Income Statement

   
     

       
 
III. Quarter
Earnings Per Share Revenues
$ -0.22 $  5,302 Mill
$-0.60     $+152M     +2.95 %
   
     
       
     
     

       
  Abbott Laboratories's Revenue rose by 2.95 % in III. Quarter (Sep 30 2016) year on year, to $5,302 million and declined by -0.58 % sequentially.

More on ABT's Growth

   
     

Abbott Laboratories is Expected to report next financial results on January 27, 2017.

       
  • Established Pharmaceutical Products 24.64% Y/Y,
• Pediatric Nutritionals 3.95% Y/Y,
• Nutritionals 0.11% Y/Y
   
     
       
  • Adult Nutritionals -1.92% Y/Y,
• Endovascular -0.77% Y/Y,
• Vascular -7.95% Y/Y,
• Diagnostics -2.03% Y/Y,
• Other -10.06% Y/Y
   
     


  • ABT's Segments
       
 
You need to upgrade your Flash Player


More on ABT's EPS
   
     
       
  ABT's NET INCOME
Abbott Laboratories's in III. Quarter recorded net loss of $-329 million, compare to net income of $580 million achieved in III. Quarter a year ago.

Sequentially company realized net loss, compare to net income of $615.00 million in previous quarter.

More on ABT's Growth
   
     
       
  • Vascular -14.64% Y/Y,
• Diagnostics -0.97% Y/Y
   
     
       
  • Established Pharmaceutical Products 10.63% Y/Y,
• Nutritionals 24.39% Y/Y
   
     

Inventories ABT's Cash flow
Inventories declined by -0.76 % to $2,613.00 million from III. Quarter a year ago, sequentially inventories fell by -7.11 %.

More on ABT's Balance Sheets
In III. Quarter company's net cash and cash equivalents decreased by $-78 million, capital expenditures fell by -149.56%, to $-312 millions compare to same quarter a year ago and fell by 26.32% from II. Quarter (Jun 30 2016).

More on ABT's Cash flow Statement
       
 
Abbott Laboratories payed out dividend of $1.02 per share in last 52 weeks representing 110.87 % of net earning per share in trailing twelve-month period.

During the same period Abbott Laboratories earned $ 1.39 cash per share, on a free-cash flow basis 151.22 % of net earning per share.

Book value grew by 0.77 % sequentially to $14.15 per share, 6.13% of net income per share in trailing twelve-month period were contributed to shareholder value.
Tangible Book value grew to $ 5.70 per share from $ 3.87.

Company repurchased 4.13 million shares or 0.28 % in III. Quarter.
Interest Coverage Ratio was 5.29. Debt Coverage Ratio was 0.19.

More on ABT's Dividends

   
     
       
 
 Market Capitalization (Millions $) 59,645
 Shares Outstanding (Millions) 1,476
 Total Debt (Millions $) 8,510
 Revenue (TTM) (Millions $) 20,708
 Net Income (TTM) (Millions $) 1,369
 Cash Flow (TTM) (Millions $) -632
 Capital Exp. (TTM) (Millions $) -1,050
 Dividend TTM ($) 1.02 $
 Dividend Yield TTM (%) 2.57 %
 Employees (TTM) $ 77,000
   
     
Economy

Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Productivity
Employment Situation
US International Trade
Factory Orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales
Stocks

Event Calendar
AA's Profile
Stock Price
AA's Financials
AA's Expectations
Business Description
Fundamentals
Charts & Quotes
AA's News
Suppliers
AA's Competitors
Customers & Markets
Economic Indicators
AA's Growth
Company Segments
Industries

At a Glance
Performance
Growth Rates
Profitability
Valuation
Financial Strength
Markets

At a Glance
Stocks
Indices
Sectors & Industries
Financials
Commodities
Currencies
Screening

Stock Performance
Growth Rates
Profitability
Valuation
Dividend
Financial Strength
Efficiency
Expectations
Management Effectivness
News

At a Glance
Stocks
Economy
Industries
Other
Glossary

Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms
Help

Sitemap
Advertise
About us
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com